Sanofi Receives Tentative FDA Approval of Admelog (insulin lispro injection) 100 units/mL

BRIDGEWATER, N.J., Sept. 1, 2017 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) granted tentative approval for Admelog ® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news